To investigate if UC-MSCs improve the impaired function of Tregs from MS, we co-cultured UC-MSCs with PBMCs from MS patients at a ratio of 1:5 for 3 days and then isolated CD4+CD25+CD127low/− Tregs for functional examination. Here, CD4 is linked to myeloid sarcoma.